NICE Recommends Drug Treatment for SMA

NICE issued a draft guidance recommending the use of risdiplam as a new drug treatment for spinal muscular atrophy (SMA)

Gene Therapy Restores Muscle Function in Kids with Spinal Muscular Atrophy

Researchers Identify New Biomarker of Alzheimer's Disease

Featured Videos

ALS - Overview

ALS - Treatment

ALS - Stress

ALS - Dietary Strategy

ALS - Exercise Strategy

Vascular Dementia - Overview

Vascular Dementia - Right Amount of Sleep

Vascular Dementia - Tips and Suggestions

Epilepsy - Facts

Epilepsy - Benefits of Sleep

Epilepsy - Benefits of Exercise

Epilepsy - Consequences of Stress

Epilepsy - Precautions

Epilepsy - The Correct Food

Epilepsy - Treatment


FDA Gives Orphan Drug Designation to Ketamine for ALS

The FDA has recently given orphan drug designation to Ketamine for treatment of Amyotrophic Lateral Sclerosis (ALS)

Trial Shows Arthritis Treatment Safe for ALS and Eases Inflammation

Tocilizumab, an established rheumatoid arthritis (RA) treatment, was found to reduce inflammation in ALS patients in a new study.

Cholesterol Metabolism Defects Linked to ALS

A new study published in the Journal of Cell Biology has linked a defect in cholesterol metabolism to the development of neurological damage caused by amyotrophic lateral sclerosis (ALS).



Study: How Effective Is Erenumab in Preventing Migraine?

A new study shows that erenumab is helpful in treating headaches and migraine in patients by blocking a certain protein in the body.


Atogepant Shows Promise In Preventing Migraines

Atogepant, a prospective drug currently being developed by AbbVie, lowered migraine days in a recent study and showed optimistic results.


COVID-19 & New-Onset Migraine and Tension-Type Headaches

A new study published in The Journal of Headache and Pain has aimed to examine the relationship between headaches and COVID-19.

Multiple Sclerosis

Study Shows Promise In J&J’s Ponvory For MS

Johnson and Johnson’s new drug to treat multiple sclerosis, Ponvory, has performed well in a recent study compared to a similar MS drug. 

MS Stem Cell Trial Receives FDA Authorization

The FDA recently approved a Phase II clinical trial which aims to treat MS patients using autologous adipose-derived mesenchymal stem cell infusions

Cognitive Rehabilitation Programs Effective In Treating MS-Related Cognitive Dysfunction

A new study has found that undergoing cognitive rehabilitation is effective at restoring cognition in individuals with MS.

Study: Newly Diagnosed MS Shows Cluster of Symptoms

A new study published in the Multiple Sclerosis Journal has found that several common symptoms of MS often cluster together for patients in their first year following diagnosis

Seizure Disorder

Seizure Disorder

A Promising New Anti-Seizure Drug Tailored to Newborns

A new study on an anti-seizure drug specifically for newborns shows promise, though further research is needed.

Seizure Disorder

Benefits From Long-Term Video EEG Monitoring in Epilepsy Patients

A new study has determined that long-term video EEG monitoring is an effective diagnostic tool for epilepsy in children.

Seizure Disorder

Cerebral Cavernous Malformations Increase Seizure Risk

A recent study found that having an inherited cerebral cavernous malformation increases an individual’s risk of seizures.

Spinal Muscular Atrophy

NICE Recommends Drug Treatment for SMA

NICE issued a draft guidance recommending the use of risdiplam as a new drug treatment for spinal muscular atrophy (SMA)

Gene Therapy Restores Muscle Function in Kids with Spinal Muscular Atrophy

Spinal muscular atrophy is a debilitating rare illness, but advances in gene therapy might prove to be the future of treatment.

Delivery Method for SMA Drug Nusinersen Evaluated for Safety and Efficacy

A new, more streamlined method of administration has recently been developed for the use of nusinersen in Spinal muscular atrophy (SMA).

Pilot Program on Newborn Screening to Find & Treat SMA

A pilot program in Australia looked at at the importance of testing for spinal muscular atrophy (SMA) in newborns.

Sleep Disorder

Sleep Disorder

Review: Type 2 Diabetes Increases Risk & Complications of Sleep Disorders

A recent review has underlined the prevalence of sleep disorders among patients with type 2 diabetes and its impact on health outcomes.

Sleep Disorder

Study: Sleep Disorders Linked with More Severe COVID-19 Outcomes

A study conducted at the Cleveland Clinic suggests some sleep disorders may be linked to more severe outcomes from COVID-19

Sleep Disorder

Xywav: A FDA-Approved Treatment for Chronic Sleep Disorder

The FDA has approved Xywav - a new treatment for idiopathic hypersomnia (an uncommon disorder that causes constant daytime sleepiness).

Send this to a friend